Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. (Q54435973)

29 May 2018

title

Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. (English)

1 reference

29 May 2018

0 references

Patrick J Shaw

1

1 reference

29 May 2018

Marie J Hopfensperger

series ordinal

2

1 reference

29 May 2018

Patricia E Ganey

series ordinal

3

1 reference

29 May 2018

Robert A Roth

series ordinal

4

1 reference

29 May 2018

publication date

19 August 2007

1 reference

29 May 2018

published in

Toxicological Sciences

1 reference

29 May 2018

volume

100

1 reference

29 May 2018

issue

1

1 reference

29 May 2018

page(s)

259-266

1 reference

29 May 2018

Comparative tolerability of the newer fluoroquinolone antibacterials

cites work

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Levofloxacin: a review of its use in the treatment of bacterial infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Adverse reactions to fluoroquinolones. an overview on mechanistic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Protection against lipopolysaccharide-induced death by fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Dalteparin sodium prevents liver injury due to lipopolysaccharide in rat through suppression of tumor necrosis factor-alpha production by Kupffer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Screening for the potential of a drug candidate to cause idiosyncratic drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFM218

21 January 2018

Identifiers

DOI

10.1093/TOXSCI/KFM218

1 reference

29 May 2018

1 reference

29 May 2018